Adverse events associated with weight-based, high-dose montelukast exposures in children

Clin Toxicol (Phila). 2020 Feb;58(2):145-146. doi: 10.1080/15563650.2019.1609686. Epub 2019 May 6.

Donald H Arnold^{1

2

3}, Nena Bowman⁴, Theodore F Reiss⁵, Tina V Hartert^{3

6}, Wendell S Akers^{7

8}, Donna L Seger^{2

4

6}

¹ Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA.
² Department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
³ Center for Asthma Research, Vanderbilt University School of Medicine, Nashville, TN, USA.
⁴ Tennessee Poison Center, Nashville, TN, USA.
⁵ Celgene Corporation, Summit, NJ, USA.
⁶ Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
⁷ Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
⁸ Department of Pharmaceutical Sciences, Lipscomb University College of Pharmacy, Nashville, TN, USA.

No abstract available

Publication types